Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Raphael Elmaleh, Ph.D.

Co-Author

This page shows the publications co-authored by David Elmaleh and Timothy Shoup.
Connection Strength

1.190
  1. Cromolyn platform suppresses fibrosis and inflammation, promotes microglial phagocytosis and neurite outgrowth. Sci Rep. 2021 11 12; 11(1):22161.
    View in: PubMed
    Score: 0.242
  2. Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's Disease. J Alzheimers Dis. 2021; 80(2):775-786.
    View in: PubMed
    Score: 0.228
  3. Synthesis of fluorine-18-labeled biotin derivatives: biodistribution and infection localization. J Nucl Med. 1994 Oct; 35(10):1685-90.
    View in: PubMed
    Score: 0.148
  4. Evaluation of (4-[18F]Fluorophenyl)triphenylphosphonium ion. A potential myocardial blood flow agent for PET. Mol Imaging Biol. 2011 Jun; 13(3):511-517.
    View in: PubMed
    Score: 0.117
  5. Detection of inflamed atherosclerotic lesions with diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography. Proc Natl Acad Sci U S A. 2006 Oct 24; 103(43):15992-6.
    View in: PubMed
    Score: 0.085
  6. Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging. J Nucl Med. 2005 Feb; 46(2):297-304.
    View in: PubMed
    Score: 0.076
  7. Preparation and biological evaluation of iodine-125-IACFT: a selective SPECT agent for imaging dopamine transporter sites. J Nucl Med. 1996 Jul; 37(7):1197-202.
    View in: PubMed
    Score: 0.042
  8. A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid ß in the brain in a transgenic model of Alzheimer disease. J Biol Chem. 2015 Jan 23; 290(4):1966-78.
    View in: PubMed
    Score: 0.037
  9. Crown ethers attenuate aggregation of amyloid beta of Alzheimer's disease. Chem Commun (Camb). 2014 Dec 25; 50(99):15792-5.
    View in: PubMed
    Score: 0.037
  10. Membrane potential-dependent uptake of 18F-triphenylphosphonium--a new voltage sensor as an imaging agent for detecting burn-induced apoptosis. J Surg Res. 2014 May 15; 188(2):473-9.
    View in: PubMed
    Score: 0.035
  11. Mannose-binding lectin binds to amyloid ß protein and modulates inflammation. J Biomed Biotechnol. 2012; 2012:929803.
    View in: PubMed
    Score: 0.031
  12. 4-[18F]-tetraphenylphosphonium as a PET tracer for myocardial mitochondrial membrane potential. JACC Cardiovasc Imaging. 2012 Mar; 5(3):285-92.
    View in: PubMed
    Score: 0.031
  13. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008 Sep 16; 71(12):903-10.
    View in: PubMed
    Score: 0.024
  14. Novel (bisarylmethoxy)butylpiperidine analogues as neurotransmitter transporter inhibitors with activity at dopamine receptor sites. Bioorg Med Chem. 2002 Dec; 10(12):4091-102.
    View in: PubMed
    Score: 0.016
  15. Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone. J Pharmacol Exp Ther. 1996 Nov; 279(2):939-47.
    View in: PubMed
    Score: 0.011
  16. Cocaine congeners as PET imaging probes for dopamine terminals. J Nucl Med. 1996 Jul; 37(7):1186-92.
    View in: PubMed
    Score: 0.010
  17. Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT. Exp Neurol. 1994 Apr; 126(2):305-9.
    View in: PubMed
    Score: 0.009
  18. PET- and MRI-based assessment of glucose utilization, dopamine receptor binding, and hemodynamic changes after lesions to the caudate-putamen in primates. Exp Neurol. 1994 Jan; 125(1):41-51.
    View in: PubMed
    Score: 0.009
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.